Sabby Management »

Akari Therapeutics Plc Sponsored shares owned by Sabby Management

Quarter-by-quarter ownership of Akari Therapeutics Plc Sponsored (AKTX) shares owned by Sabby Management from 13F filings

Historical chart of Sabby Management investment in Akari Therapeutics Plc Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Akari Therapeutics Plc Sponsored held by Sabby Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akari Therapeutics Plc Sponsored by Sabby Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $90k 49k 1.87

More positions owned by Sabby Management

Spdr S&p 500 Etf Tr Etf Put Option
Ishares Tr Etf Put Option
Spdr S&p 500 Etf Tr Etf Call Option
Ishares Tr Etf Call Option
Vivani Medical (VANI)
Eltek SHS (ELTK)
Core Scientific Note (Principal)
Redhill Biopharma Ads (RDHL)
Tonix Pharmaceuticals Hldg
Global Mofy Metaverse Ord (GMM)
China Natural Resources SHS (CHNR)
Checkpoint Therapeutics Put Option
Bit Digital SHS Put Option
Recon Technology Cl A
Biovie Cl A (BIVI)

View all positions for Sabby Management

Top funds holding Akari Therapeutics Plc Sponsored

Omnia Family Wealth
Citadel Advisors
HPM Partners
Renaissance Technologies
Bank of America Corporation
Advisor Group Holdings
Morgan Stanley
Cornerstone Planning Group

View all funds holding Akari Therapeutics Plc Sponsored